Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Cognitive behavioral strategies help women with PCOS make lifestyle changes to improve their health.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Finasteride worsens seizures in epilepsy rats and speeds up epileptogenesis in mice.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Acne is an important sign of androgen excess disorders in women.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

The study found three different timing patterns of symptoms in women with premenstrual dysphoric disorder.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Primary care for PCOS focuses on lifestyle changes, medication based on symptoms, and mental health, with diabetes screening and specialist referral for severe cases.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

Birth control pills can help reduce mild to moderate acne in women.

Timing of light therapy affects horse coat growth, with photoperiod being crucial.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Women with congenital adrenal hyperplasia have lower fertility, but with proper treatment, they can conceive successfully.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.